|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/115 | |
| C12Q 1/68 | |||
| A61K 31/7088 |
| (11) | Number of the document | 2578683 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13150168.6 |
| Date of filing the European patent application | 2005-02-14 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 544542 P | 2004-02-12 | US | |
| 547747 P | 2004-02-25 | US | |
| 581685 P | 2004-06-21 | US | |
| 608048 P | 2004-09-07 | US |
| (72) |
Benedict, Claude, US
Diener, John, US
Epstein, David, US
Grate, Dilara, US
Keene, Sara Chesworth, US
Kurz, Jeffrey, US
Kurz, Markus, US
McCauley, Thomas Green, US
Rottman, James, US
Thompson, Kristin, US
Wilson, Charles, US
Zoltoski, Anna J., US
|
| (73) |
Archemix LLC,
601 Montgomery Street, Suite 2020, San Francisco, CA 94111,
US
|
| (54) | Aptamer therapeutics useful in the treatment of complement-related disorders |
| Aptamer therapeutics useful in the treatment of complement-related disorders |